دورية أكاديمية

One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.

التفاصيل البيبلوغرافية
العنوان: One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
المؤلفون: Gu, Maggie, Torres, Jonathan L., Li, Yijia, Van Ry, Alex, Greenhouse, Jack, Wallace, Shannon, Chiang, Chi-I, Pessaint, Laurent, Jackson, Abigail M., Porto, Maciel, Kar, Swagata, Li, Yuxing, Ward, Andrew B., Wang, Yimeng
المصدر: Emerging Microbes & Infections; Dec 2021, Vol. 10 Issue 1, p2016-2029, 14p
قاعدة البيانات: Complementary Index
الوصف
تدمد:22221751
DOI:10.1080/22221751.2021.1994354